CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ORICOric Pharmaceuticals, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $13.47 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$1.40B
RECENT INSIDER TRADES
  • 2026-10-02 · Heyman Richard A. (Director) · SELL
  • 2026-10-02 · Heyman Richard A. (Director) · OTHER
  • 2026-09-29 · Piscitelli Dominic (Chief Financial Officer) · OTHER
  • 2026-09-29 · Piscitelli Dominic (Chief Financial Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders190
Shares held140,175,910
Value$1.40B
Percent of shares outstanding135.24%
As of quarter end2026-06-30
RECENT NEWS
  • ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development
  • ORIC Pharmaceuticals grants 161,550 stock options and 26,850 RSUs to six employees
  • Oric Pharma CFO sells $181k in shares
  • Oric Pharmaceuticals CFO Dominic Piscitelli sells $8,102 in shares
  • ORIC Pharmaceuticals presents at Morgan Stanley healthcare conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Oric Pharmaceuticals, Inc. (ORIC) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit